Advertisement

Ads Placeholder
Loading...

DBV Technologies S.A.

DBV.PAEURONEXT
Healthcare
Biotechnology
3.63
-0.12(-3.07%)
U.S. Market opens in 54h 37m

DBV Technologies S.A. Fundamental Analysis

DBV Technologies S.A. (DBV.PA) shows weak financial fundamentals with a PE ratio of -5.45, profit margin of -195.50%, and ROE of -1.89%. The company generates $0.0B in annual revenue with weak year-over-year growth of -73.61%.

Key Strengths

Cash Position27.89%
PEG Ratio-5.34
Current Ratio3.67

Areas of Concern

ROE-1.89%
Operating Margin-200.17%
We analyze DBV.PA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -14897.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-14897.7/100

We analyze DBV.PA's fundamental strength across five key dimensions:

Efficiency Score

Weak

DBV.PA struggles to generate sufficient returns from assets.

ROA > 10%
-62.98%

Valuation Score

Excellent

DBV.PA trades at attractive valuation levels.

PE < 25
-5.45
PEG Ratio < 2
-5.34

Growth Score

Weak

DBV.PA faces weak or negative growth trends.

Revenue Growth > 5%
-73.61%
EPS Growth > 10%
-64.79%

Financial Health Score

Excellent

DBV.PA maintains a strong and stable balance sheet.

Debt/Equity < 1
0.13
Current Ratio > 1
3.67

Profitability Score

Weak

DBV.PA struggles to sustain strong margins.

ROE > 15%
-189.50%
Net Margin ≥ 15%
-195.50%
Positive Free Cash Flow
No

Key Financial Metrics

Is DBV.PA Expensive or Cheap?

P/E Ratio

DBV.PA trades at -5.45 times earnings. This suggests potential undervaluation.

-5.45

PEG Ratio

When adjusting for growth, DBV.PA's PEG of -5.34 indicates potential undervaluation.

-5.34

Price to Book

The market values DBV Technologies S.A. at 4.75 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.75

EV/EBITDA

Enterprise value stands at -6.41 times EBITDA. This is generally considered low.

-6.41

How Well Does DBV.PA Make Money?

Net Profit Margin

For every $100 in sales, DBV Technologies S.A. keeps $-195.50 as profit after all expenses.

-195.50%

Operating Margin

Core operations generate -200.17 in profit for every $100 in revenue, before interest and taxes.

-200.17%

ROE

Management delivers $-1.89 in profit for every $100 of shareholder equity.

-1.89%

ROA

DBV Technologies S.A. generates $-62.98 in profit for every $100 in assets, demonstrating efficient asset deployment.

-62.98%

Following the Money - Real Cash Generation

Operating Cash Flow

DBV Technologies S.A. generates limited operating cash flow of $-107.45M, signaling weaker underlying cash strength.

$-107.45M

Free Cash Flow

DBV Technologies S.A. generates weak or negative free cash flow of $-107.93M, restricting financial flexibility.

$-107.93M

FCF Per Share

Each share generates $-0.64 in free cash annually.

$-0.64

FCF Yield

DBV.PA converts -17.27% of its market value into free cash.

-17.27%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.45

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-5.34

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.75

vs 25 benchmark

P/S Ratio

Price to sales ratio

939.94

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.13

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.67

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.89

vs 25 benchmark

ROA

Return on assets percentage

-0.63

vs 25 benchmark

ROCE

Return on capital employed

-0.86

vs 25 benchmark

How DBV.PA Stacks Against Its Sector Peers

MetricDBV.PA ValueSector AveragePerformance
P/E Ratio-5.4528.45 Better (Cheaper)
ROE-189.50%763.00% Weak
Net Margin-19549.80%-45265.00% (disorted) Weak
Debt/Equity0.130.34 Strong (Low Leverage)
Current Ratio3.672795.60 Strong Liquidity
ROA-62.98%-16588.00% (disorted) Weak

DBV.PA outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews DBV Technologies S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

77.73%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

75.60%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ